House Bill 309
115th Congress(2017-2018)
National Clinical Care Commission Act
Active
Passed House on Jan 9, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
309
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on January 9, 2017
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H201-202)
Summary
National Clinical Care Commission Act
This bill amends the Public Health Service Act to establish within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and recommend solutions regarding better coordination and leveraging of federal programs that relate to supporting clinical care for individuals with complex metabolic or autoimmune disease, diabetes, or complications caused by such diseases.
The duties of the commission include:
- evaluating HHS programs regarding the utilization of preventive health benefits,
- identifying current activities and gaps in federal efforts to support clinicians in providing integrated care,
- making recommendations regarding the development and coordination of federally funded clinical practice support tools,
- recommending clinical pathways for new technologies and treatments,
- evaluating and expanding education and awareness activities provided to health care professionals, and
- reviewing and recommending methods for outreach and dissemination of educational resources.
The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
January 10, 2017
January 9, 2017
January 5, 2017
01/10/2017
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
01/09/2017
Motion to reconsider laid on the table Agreed to without objection.
01/09/2017
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H201-202)
01/09/2017
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H201-202)
01/09/2017
DEBATE - The House proceeded with forty minutes of debate on H.R. 309.
01/09/2017
Considered under suspension of the rules. (consideration: CR H201-203)
01/09/2017
Mr. Burgess moved to suspend the rules and pass the bill.
01/05/2017
Referred to the House Committee on Energy and Commerce.
01/05/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:34:32 PM